NRIP1 is a regulator of oncogenic signaling pathways in chronic lymphocytic leukemia and a therapeutic target to sensitize acute myeloid leukemia to all-trans retinoic acid28,29. Here, NRIP1 is linked to acute myeloid leukemia.